PTHvsARKGETF Comparison
VS
Invesco DWA Healthcare Momentum ETF (PTH) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PTH is less expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.75% for ARKG. PTH is up 17.82% year-to-date (YTD) with +$88M in YTD flows. ARKG performs better with 29.47% YTD performance, and +$39M in YTD flows. Run a side-by-side ETF comparison of PTH and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PTH vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PTH ARKG | +5.19%-1.87% | +12.36%+27.92% | +17.82%+29.47% | +58.30%+45.31% | +56.89%+4.16% | +7.61%-54.66% |
| Flows | PTH ARKG | +$102M+$81M | +$94M+$62M | +$88M+$39M | +$92M-$3M | +$25M-$550M | -$192M-$2.57B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PTH ARKG | +29.53%+44.86% | +24.63%+42.64% | +25.60%+43.40% | +25.58%+45.98% |
| Max drawdown | PTH ARKG | -8.31%-13.14% | -11.91%-27.52% | -27.71%-51.67% | -50.10%-79.29% |
| Max drawdown duration | PTH ARKG | 41d18d | 140d126d | 353d1058d | 1756d1814d |
Trading data
PTH | ARKG | |
Last sale 7/24/2026 at 1:30 PM | $58.57 | $37.81 |
| Previous close 07/23/2026 | $59.39 | $38.82 |
| Consolidated volume 07/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexPTH | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
PTH | ARKG | |
|---|---|---|
| Last price | $58.57 | $37.81 |
| 1D performance | -1.38% | -2.60% |
| AuM | $231.95 M | $1.53 B |
| E/R | 0.72% | 0.75% |
Characteristics
PTH | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Ark Investment |
| Benchmark | Dorsey Wright Healthcare Technical Leaders Index | - |
| N° of holdings | 57 | 31 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 12, 2006 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
PTH
USA
92.25%
Other
7.75%
ARKG
USA
86.99%
Other
13.01%
Sectors
PTH
Healthcare
100%
Other
0%
ARKG
Healthcare
96.93%
Other
3.07%
Advertisement
Diversification
PTH
Total weight of top 15 holdings out of 15
43.88%
ARKG
Total weight of top 15 holdings out of 15
74.95%
Top 15 holdings
Data as of June 30, 2026
PTH
Roivant Sciences Ltd.
4.95%
Praxis Precision Medicines, Inc.
4.66%
Tango Therapeutics, Inc.
3.70%
SELLAS Life Sciences Group, Inc.
3.36%
United Therapeutics Corp.
2.91%
Tenet Healthcare Corp.
2.89%
Axsome Therapeutics, Inc.
2.74%
BrightSpring Health Services, Inc.
2.54%
Liquidia Corp.
2.52%
Moderna, Inc.
2.49%
Ionis Pharmaceuticals, Inc.
2.30%
Erasca, Inc.
2.29%
HCA Healthcare, Inc.
2.23%
Twist Bioscience Corp.
2.21%
Protagonist Therapeutics, Inc.
2.08%
ARKG
Twist Bioscience Corp.
9.15%
Tempus AI, Inc.
7.64%
Absci Corp.
7.01%
10X Genomics, Inc.
7.00%
CRISPR Therapeutics AG
6.56%
Personalis, Inc.
6.19%
Beam Therapeutics, Inc.
4.34%
Guardant Health, Inc.
4.28%
Natera, Inc.
4.11%
Illumina, Inc.
3.98%
Veracyte, Inc.
3.24%
CareDx, Inc.
3.08%
Recursion Pharmaceuticals, Inc.
2.85%
Eli Lilly & Co.
2.81%
Compass Pathways Plc
2.70%
Frequently asked questions about PTH and ARKG
How have the PTH and ARKG ETFs performed in 2026?
As of July 24, 2026, PTH is up 17.82% year-to-date (YTD), while ARKG has returned 29.47%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: PTH or ARKG?
Year-to-date, the PTH ETF saw +$88M in flows, compared to +$39M for ARKG.
Which ETF is more volatile: PTH or ARKG?
Over the past year, PTH had a volatility of 24.63%, while ARKG experienced 42.64%.
Which ETF is bigger: PTH or ARKG?
As of July 24, 2026, PTH holds $231.95 M in assets under management (AUM), while ARKG manages $1.53 B.
What sectors do the PTH and ARKG ETFs invest in?
PTH leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the PTH ETF and ARKG ETF?
PTH top holdings include Roivant Sciences Ltd., Praxis Precision Medicines, Inc. and Tango Therapeutics, Inc.. ARKG holds in its top three: Twist Bioscience Corp., Tempus AI, Inc. and Absci Corp..
Which ETF is more diversified: PTH or ARKG?
PTH holds 57 securities with 43.88% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 74.95%.
Advertisement
Latest news about PTH & ARKG
Continued tightening of the U.S. labor market
September 23, 2022
PTH
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
